A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-03-31

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Buprenorphine Maintenance for Opioid Addicts - 2

NCT00000203

Opioid-Related Disorders

COMPLETED PHASE2

Buprenorphine Maintenance for Opioid Addicts - 3

NCT00000204

Opioid-Related Disorders

COMPLETED PHASE2

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

NCT00000319

COMPLETED PHASE2

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

NCT00555425

Opiate Dependence

COMPLETED PHASE4

Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance

NCT00622596

Opiate Dependence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will consent to in-person assessments and monthly chart reviews. We anticipate that the results from this study will inform the development of future services targeted towards adolescents and young adults with opioid dependence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naturalistic Prospective Cohort

Follow subjects through 1 year of naturalistic buprenorphine treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 16 through 25 at time of induction
* Meet criteria for enrollment in the APT Adolescent and Young Adult Suboxone Program (Opioid Dependence per DSM-V criteria; no contraindications to buprenorphine (concomitant benzodiazepine, alcohol use, sedative use),
* Stable enough to participate in outpatient care/intensive outpatient care for at least 12 weeks;
* Can commit to at least 12 weeks of treatment through the APT Adolescent and Young Adult Suboxone Program
* Are willing to provide locator information for follow-up.
* Are fluent in English and have a 6th grader or higher reading level

Exclusion Criteria

* Have an untreated bipolar or schizophrenic disorder, or active suicidal ideation
* Are physically dependent on alcohol, benzodiazepines, or other sedatives.
* Are in custody of the Department of Children and Families

Minimum Eligible Age

16 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No